Home > National Drug Code (NDC) > CENTUSSIN DHC

CENTUSSIN DHC - 23359-018-16 - (Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride)

Alphabetical Index


Drug Information of CENTUSSIN DHC

Product NDC: 23359-018
Proprietary Name: CENTUSSIN DHC
Non Proprietary Name: Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride
Active Ingredient(s): 4; 3; 7.5    mg/5mL; mg/5mL; mg/5mL & nbsp;   Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of CENTUSSIN DHC

Product NDC: 23359-018
Labeler Name: Centurion Labs, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20091124

Package Information of CENTUSSIN DHC

Package NDC: 23359-018-16
Package Description: 473 mL in 1 BOTTLE (23359-018-16)

NDC Information of CENTUSSIN DHC

NDC Code 23359-018-16
Proprietary Name CENTUSSIN DHC
Package Description 473 mL in 1 BOTTLE (23359-018-16)
Product NDC 23359-018
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Dihydrocodeine Bitartrate, Brompheniramine Maleate, and Phenylephrine Hydrochloride
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20091124
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name Centurion Labs, LLC
Substance Name BROMPHENIRAMINE MALEATE; DIHYDROCODEINE BITARTRATE; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 4; 3; 7.5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of CENTUSSIN DHC


General Information